Johnson drug hit by blood cancer fears
77718
US drug giant Johnson &amp; Johnson added to concerns over drug safety yesterday by announcing that its arthritis drug Remicade would have its labelling revised to reflect a higher risk of blood cancer for patients.
544009
THURSDAY, Dec. 13 (HealthDay News) -- The new and powerful cancer drug sunitinib (Sutent), which fights stomach tumors, can also create heart problems for some patients, a new study finds.
61937
NEW YORK - Johnson &amp; Johnson and Boston Scientific Corp. reported new safety data yesterday for drug-coated stents that may help revive sales depressed by prior reports linking the devices to a higher risk of heart attacks.
506148
It's running trials to see if the drug can be used in earlier stages of cancer.
430832
WASHINGTON  New warnings on anemia drugs  Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.
267992
Dying of lung cancer, Carolyn Hobbs tried a new biotechnology drug that produced an unanticipated side effect: acute sticker shock. She was waiting for her second treatment in a hospital near Denver less than two years ago, when someone from the business office marched in to warn that her share would cost more than $18,000, since the drug wasn't insured for her type of cancer.
462742
People who use the drug Remicade for rheumatoid arthritis may be at increased risk of a serious blood disorder, the US Food and Drug Administration warned.
10877
WEDNESDAY, Feb. 13 (HealthDay News) -- A greater percentage of patients than previously thought may develop heart failure when taking the breakthrough cancer drug Sutent, researchers report.
12582
A vaccine to help patients fend of blood cancers could be a reality in the near future.
570428
Concern over the recently publicized risks of drugs such as Vioxx and Celebrex has left doctors and patients with difficult choices.
285787
A drug used to limit blood loss while patients undergo coronary-artery bypass surgery also carries a higher five-year risk of death than cheaper generic alternatives, a researcher said on Tuesday.
33587
Amgen Inc. and Johnson & Johnson anemia drugs will carry strong new warnings after studies showed a higher risk of death and life-threatening side effects in some patients, U.S. health officials said on Friday.
265022
There is concern British soldiers in Iraq and Afghanistan are being treated with a drug that has not been fully tested and licensed.
93502
Company warns Remicade may up risk of lymphoma, label changed for second time to reflect hazards. NEW YORK  - Johnson &amp; Johnson is warning doctors that patients taking its rheumatoid arthritis drug
202746
Johnson & Johnson JNJ.N is warning  doctors that patients taking its rheumatoid arthritis drug  Remicade may have a higher risk of lymphoma, a blood cancer,  the company said on Friday.
556746
NEW YORK  - Drugs used to treat malaria appear to reduce the risk of malignancy in patients with systemic lupus erythematosus, Spanish researchers report in the Annals of the Rheumatic Diseases.
538035
Users of an anti-arthritis drug linked by a study to an increased risk of heart attacks and strokes have been urged not to panic. The UK Department of Health said users of Celebrex, manufactured by US drug